Nov 07, 2024 / 09:30PM GMT
Operator
Good afternoon, ladies and gentlemen. Welcome to the Kura Oncology third-quarter 2024 financial results call. (Operator Instructions) Also, today's call is being recorded.
Now at this time, I'll turn things over to Mr. Pete De Spain, Head of Investor Relations. Please go ahead, sir.
Pete De Spain - Kura Oncology Inc - Head of Investor Relations
Great. Thank you, Bo. Good afternoon, and welcome to Kura Oncology's Third Quarter 2024 Conference Call. Joining me on the call are Dr. Troy Wilson, our President and Chief Executive Officer; and Tom Doyle, our Senior Vice President of Finance and Accounting; Dr. Mollie Leoni, our Executive Vice President of Clinical Development, is also with us and available to answer. Before I turn the call over to Dr. Wilson, I'd like to remind you that today's call will include forward-looking statements based on current expectations. Such statements represent management's judgment as of today and may involve risks and uncertainties that could cause actual results to differ materially from expected results. Please refer to
Q3 2024 Kura Oncology Inc Earnings Call Transcript
Nov 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers